Summary: Myriad's Precise MRD test is an ultrasensitive second-generation hybrid-capture-based tumor-informed assay that ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that its ultra-sensitive ...

Shares of Exact Sciences Corp. (EXAS) traded over 2% higher on Tuesday afternoon after the company launched a new test ...

The Ministry of Rural Development (MRD) will soon commence spot monitoring of Constituency Development Funds (CDF) projects in all the 50 constituencies. This is to gauge the level of project ...

Corp announced the launch of Oncodetecta-a new test designed to detect molecular residual disease, MRD, across multiple ...

Ein republikanischer Vorschlag zur Erhöhung der Steuern für Millionäre könnte den USA über einen Zeitraum von zehn Jahren ...

State Health Officer Dr. Scott Harris announced Thursday the reopening of portions of Mobile Bay that were temporarily closed ...

The Oncodetect test detects molecular residual disease across solid tumors using circulating tumor DNA to inform recurrence ...

The North American minimal residual disease (MRD) testing market is poised for substantial growth in the coming years. With a projected annual increase of 11.1% throughout the forecast period, ...

Renovaro Inc. (NASDAQ: RENB) , an AI-driven precision Medicine Company that leverages AI platforms to improve outcomes for cancer and neurologically challenged patients, today announced is expanding ...

The Ministry of Rural Development (MRD) will soon commence spot monitoring of Constituency Development Funds (CDF) projects in all the 50 constituencies. This is to gauge the level of project ...